{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:42:36Z","timestamp":1776854556464,"version":"3.51.2"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.0005","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T16:55:48Z","timestamp":1552064148000},"page":"e190005","source":"Crossref","is-referenced-by-count":31,"title":["Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke"],"prefix":"10.1001","volume":"2","author":[{"given":"Joseph","family":"Scarpa","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Bruzelius","sequence":"additional","affiliation":[{"name":"Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Doupe","sequence":"additional","affiliation":[{"name":"Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Le","sequence":"additional","affiliation":[{"name":"Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Faghmous","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Palo Alto, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Baum","sequence":"additional","affiliation":[{"name":"Department of Health System Design and Global Health, Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"issue":"6","key":"zoi190001r1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"10022","key":"zoi190001r2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"zoi190001r3","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"10017","key":"zoi190001r4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"zoi190001r5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrendo.2016.209","article-title":"Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.","volume":"13","author":"Sarafidis","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"zoi190001r6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/j.ajkd.2017.08.021","article-title":"Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"71","author":"Rocco","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"zoi190001r7","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes.","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"issue":"7557","key":"zoi190001r8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality.","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"issue":"10","key":"zoi190001r9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.7326\/0003-4819-154-10-201105170-00008","article-title":"Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions.","volume":"154","author":"VanderWeele","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi190001r11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.7326\/M16-1756","article-title":"Detecting heterogeneous treatment effects to guide personalized blood pressure treatment: a modeling study of randomized clinical trials.","volume":"166","author":"Basu","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi190001r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"issue":"5","key":"zoi190001r13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"1","key":"zoi190001r14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"1","key":"zoi190001r15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/pan\/mpr025","article-title":"Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies.","volume":"20","author":"Hainmueller","year":"2012","journal-title":"Polit Anal"},{"issue":"4","key":"zoi190001r19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00004872-200304000-00024","article-title":"Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?","volume":"21","author":"Zanchetti","year":"2003","journal-title":"J Hypertens"},{"issue":"9118","key":"zoi190001r20","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial.","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"zoi190001r21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/00004872-200304000-00010","article-title":"Intensive blood pressure treatment: beneficial for all but the smoking hypertensives?","volume":"21","author":"Lund-Johansen","year":"2003","journal-title":"J Hypertens"},{"issue":"10","key":"zoi190001r22","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.CIR.102.10.1079","article-title":"New issues in the treatment of isolated systolic hypertension.","volume":"102","author":"Kaplan","year":"2000","journal-title":"Circulation"},{"issue":"9207","key":"zoi190001r23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","article-title":"Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.","volume":"355","author":"Staessen","year":"2000","journal-title":"Lancet"},{"issue":"17","key":"zoi190001r24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/CIRCULATIONAHA.116.025322","article-title":"Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the United States: projections from NHANES (National Health and Nutrition Examination Survey).","volume":"135","author":"Bress","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"zoi190001r25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13054-017-1611-7","article-title":"Blood pressure and acute kidney injury.","volume":"21","author":"Sato","year":"2017","journal-title":"Crit Care"},{"issue":"7","key":"zoi190001r26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/aor.2015.39.issue-7","article-title":"The frequency and outcome of acute kidney injury in a tertiary hospital: which factors affect mortality?","volume":"39","author":"Ulusoy","year":"2015","journal-title":"Artif Organs"},{"key":"zoi190001r16","doi-asserted-by":"crossref","DOI":"10.3386\/w21842","volume-title":"Using Split Samples to Improve Inference About Causal Effects","author":"Fafchamps","year":"2016"},{"key":"zoi190001r10","unstructured":"WagerS, AtheyS. Estimation and inference of heterogeneous treatment effects using random forests.https:\/\/arxiv.org\/pdf\/1510.04342.pdf. Published July 11, 2017. Accessed January 15, 2019."},{"key":"zoi190001r17","unstructured":"National Heart, Lung, and Blood Institute. Biologic Specimen and Data Repository Information Coordinating Center: Systolic Blood Pressure Intervention Trial Primary Outcome Paper (SPRINT-POP) data. https:\/\/biolincc.nhlbi.nih.gov\/studies\/sprint_pop\/. Published November 2015. Accessed January 9, 2019."},{"key":"zoi190001r18","unstructured":"GitHub. DEPRECATED causalForest. https:\/\/github.com\/swager\/causalForest. Accessed January 9, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/3\/e190005\/17440192\/scarpa_2019_oi_190001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:56:46Z","timestamp":1721062606000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.0005"}},"subtitle":["A Secondary Analysis of the Systolic Blood Pressure Intervention Trial"],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.0005","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]}}}